Clin2
NCT05805566Possibly a fitRecruiting

Study of care for long COVID symptoms in adults

Post-Covid Syndrome

Treatments studied

Part of Infections, Lungs & breathing clinical trials.

This study follows people who enter a specialized care pathway for long COVID (post-COVID syndrome) to better understand symptoms, needs, and outcomes. It may help improve how multidisciplinary care is organized for long COVID over time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
750 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You joined the Epsilon care pathway since it started in February 2022.
  • Your COVID illness included documented COVID pneumonia (confirmed in records).
  • You have ongoing symptoms: severe symptoms after 4 weeks, or complex/disabling symptoms lasting more than 3 months.
  • Your symptoms led to referral to the Epsilon care team either from city medicine or after a hospital stay for oxygen therapy for at least 48 hours.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07356570Recruiting
Post-COVID care tracking study for long-term symptoms

This study follows people with lasting or complex COVID-19 symptoms who are already in a specialized care program. It aims to better understand and improve recovery after COVID.

Pierre-Bénite
NCT06765421Not yet recruiting
Long COVID care improvement study

This study tests an educational program for general practitioners to improve care for patients with long COVID. It may help if you have had symptoms lasting four weeks or more after COVID-19.

NCT06597682Not yet recruiting
Study of treatments for long COVID

This trial is testing treatments for people with long COVID, which is when symptoms last more than 3 months after a COVID-19 infection. The trial focuses on three specific symptom groups: heart inflammation, cough, or severe fatigue with signs of inflammation. It aims to find if certain immune-modulating therapies can help.

Shanghai, Shanghai Municipality
NCT07074158Enrolling by invitation
Looking for long COVID clues in blood

This study compares the blood of people with ongoing long COVID symptoms to healthy people, to look for differences in immune signals and gut bacteria. It could help find better ways to diagnose or treat long COVID.

Palo Alto, California
NCT05610436Recruiting
Long COVID patients: tracking symptoms and outcomes over time

This study follows people who have ongoing symptoms after COVID (“post-Covid condition”) to better understand how symptoms change and what factors affect recovery. It may help improve care for patients seen at a Long COVID support clinic.

Vandœuvre-lès-Nancy, Grand Est
NCT04679584Recruiting
Study of long-term effects after COVID-19 infection

This study looks at how COVID-19 can affect health and quality of life over the long term. It may help researchers understand symptoms that can last and what changes people experience after recovery.

Würzburg, Bavaria

Hear when a new Post COVID Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.